A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue

Clinical trial NCT02109029 · COMPLETED

Trial details

NCT number: NCT02109029
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2014-04-01
Primary completion: 2015-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.